Qiang Huo
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Biomedical Engineering top 10%
- Pathology and Forensic Medicine top 5%
- Topics
- Cancer Mechanisms and Therapy (7 papers)Magnolia and Illicium research (5 papers)Peptidase Inhibition and Analysis (5 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Qiang Huo
37 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 624
- Cancer Research 484
- Oncology 363
- Biomedical Engineering 265
- Pathology and Forensic Medicine 259
Countries citing papers authored by Qiang Huo
This map shows the geographic impact of Qiang Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiang Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiang Huo more than expected).
Fields of papers citing papers by Qiang Huo
This network shows the impact of papers produced by Qiang Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiang Huo. The network helps show where Qiang Huo may publish in the future.
Co-authorship network of co-authors of Qiang Huo
This figure shows the co-authorship network connecting the top 25 collaborators of Qiang Huo. A scholar is included among the top collaborators of Qiang Huo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiang Huo. Qiang Huo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 4 | |
| 4 | 65 | |
| 5 | 127 | |
| 6 | 19 | |
| 7 | 2 | |
| 8 | [Transglycosylation of neolignans by enzymatic synthesis and evaluation of their antitumor activity]. | 1 |
| 9 | 6 | |
| 10 | 5 | |
| 11 | 38 | |
| 12 | 12 | |
| 13 | 44 | |
| 14 | 27 | |
| 15 | 29 | |
| 16 | 42 | |
| 17 | 129 | |
| 18 | 66 | |
| 19 | 66 | |
| 20 | 64 |
About Qiang Huo
Qiang Huo is a scholar working on Rehabilitation, Cancer Research and Oncology, having authored 38 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (7 papers), Magnolia and Illicium research (5 papers) and Peptidase Inhibition and Analysis (5 papers). The work is most often cited by research in Cancer Research (484 citations), Biomaterials (244 citations) and Pathology and Forensic Medicine (259 citations). Qiang Huo has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Qifeng Yang, Ning Zhang, Xiaolong Wang, Yimin Niu, Huihui Shi, Jianhua Zhu, Chang Cai, Meena S. Moran, Yang Liu and Bing Chen. Their work appears in journals such as Journal of Biological Chemistry, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.